Clin2
NCT07349212Possibly a fitRecruiting

Study of UKK-0018 for peanut allergy treatment

Peanut-Induced AnaphylaxisPeanut Allergy

Part of Immune system & allergy clinical trials.

This trial tests a new immunotherapy called UKK-0018 to treat peanut allergies in adults. The goal is to help your body become less sensitive to peanuts over time.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
40 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old
  • A doctor has confirmed you have a peanut allergy
  • You had a positive skin prick test for peanut allergy
  • You are willing to use birth control if needed
  • You can understand and sign a consent form

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04163562Recruiting· Phase 1/Phase 2
Oral peanut treatment trial for people with peanut allergy

This trial tests an oral (by mouth) immune treatment for people with confirmed peanut allergy. It aims to see whether your immune system can become less reactive to peanuts over time, while keeping you safe during testing with careful emergency planning.

Pamplona, Navarre
NCT07117669Recruiting· Phase 1/Phase 2
Testing a new peanut allergy treatment (ENP-501)

This trial tests a new peanut allergy treatment called ENP-501. It aims to see if the medicine can safely help people with peanut allergy become less sensitive to peanuts.

Aurora, Colorado
NCT03936998Recruiting· Phase 1/Phase 2
Study drug for peanut allergy to change immune response

This early-phase study tests VE416, a treatment meant to help reduce peanut allergy reactions by changing how the immune system responds. If you have documented peanut allergy, you may receive the study medicine and, for some people, take part in a supervised peanut “entry challenge.”

Boston, Massachusetts
NCT07015996Recruiting· Phase 2
Tezepelumab for peanut allergy oral immunotherapy

This trial tests whether adding tezepelumab (a biologic drug) to peanut oral immunotherapy can help people with peanut allergy better tolerate small amounts of peanut protein without having an allergic reaction.

Little Rock, Arkansas
NCT05695261Recruiting· Phase 2
Oral microbiome capsules for peanut allergy in teens

This Phase 2 study tests whether taking capsules made from donor gut microbes is safe and can reduce allergic reactions to peanuts. It involves peanut allergy testing and close follow-up with stool samples and check-ins.

Boston, Massachusetts
NCT07439406Not yet recruiting· Phase 2
Comparing standard and autoclaved peanut immunotherapy for peanut allergy

This study compares two types of peanut oral immunotherapy (a treatment that helps you build tolerance to peanuts) — one with standard peanuts and one with autoclaved (specially heat-treated) peanuts. It is for people with peanut allergy and aims to see which approach is safer and more effective.

Montreal, Quebec

Hear when a new Peanut Allergy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.